Amarin Corp Plc (AMRN)

[rafunrafun]

Pacer update.

#390.

April 21, 2020 NOTICE OF DOCKETING Federal Circuit Docket No.: 2020-1723 ’S CLERK 202275 OFFICE 8000 Federal Circuit Short Title: Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Date of Docketing: April 21, 2020 Originating Tribunal: United States District Court for the District of Nevada Originating Case No.: 2:16-cv-02525-MMD-NJK Appellants: Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited A notice of appeal has been filed and assigned the above Federal Circuit case number. The court's official caption is included as an attachment to this notice. Unless otherwise noted in the court's rules, the assigned docket number and official caption or short title must be included on all documents filed with this Court. It is the responsibility of all parties to review the Rules for critical due dates. The assigned deputy clerk is noted below and all case questions should be directed to the Case Management Team at [phone]. The following documents are due within 14 days of this notice: • Entry of Appearance. (Fed. Cir. R. 47.3.) • Certificate of Interest. (Fed. Cir. R. 47.4.) • Docketing Statement. Note: The Docketing Statement is due in 30 days if the United States or its officer or agency is a party in the appeal. (Fed. Cir. R. 33.1 and the Mediation Guidelines) • Statement Concerning Discrimination in MSPB cases. (Fed. Cir. R. 15(c).) PARTY FILING AND CONTACT INFORMATION: Each counsel representing a party must be a member of the court's bar and registered for the court's electronic filing .